Health care advances raise big fiscal, ethical questions
By Ira Zunin
Posted on September 3, 2016 12:05 am
Updated on September 21, 2018 at 4:26 pm
Given the current trajectory of pharmaceutical and biotechnical developments in the treatment of cancer, inherited diseases and infection, modern health care is on the precipice of unprecedented transformation.